It literally goes back to evolution.

Eye imaging may help distinguish ALS from Alzheimer’s disease by revealing differences in retinal protein deposits using polarized light.

Anavex’s precision medicine approach recognizes that Alzheimer’s pathology is heterogeneous, but autophagy dysfunction represents a causative co-factor that precedes divergent downstream ...

Alzheimer’s disease is one of the most feared conditions of aging. It slowly affects memory, thinking, and daily life, and there is still no cure. Many people wonder what they can do to lower their ...

A study in the journal Neurology has shown that people with type 1 diabetes are three times more likely to develop dementia ...

People with a genetic risk for Alzheimer's disease did not have an expected increase in cognitive decline or dementia if they consumed relatively large amounts of meat, a Swedish cohort study showed.

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they consumed relatively large amounts of meat.

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease.

A major new study finds people with type 1 diabetes face nearly three times the dementia risk. But lifestyle changes and new treatments offer real hope.

As the inaugural Director of the new Parkinson's Research Centre, funded by the UK Dementia Research Institute and Parkinson's UK, Professor Miratul Muqit (University of Dundee, UK) hopes to untangle ...

Previous research has suggested a potential link between type 2 diabetes and dementia risk. However, a new study suggests that the risk of dementia may be even higher for those living with type 1 ...